1h Free Analyst Time
The point-of-care testing (poct) market in europe is forecasted to grow by USD 8.24 billion during 2025-2030, accelerating at a CAGR of 8.8% during the forecast period. The report on the point-of-care testing (poct) market in europe provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by shift toward rapid diagnostics over traditional labs, expansion of telemedicine and remote patient services, growing geriatric population requiring frequent monitoring.
The study identifies the adoption of ai and data analytics in poct as one of the prime reasons driving the point-of-care testing (poct) market in europe growth during the next few years. Also, advancements in microfluidic and lab‑on‑chip technologies and expansion of otc poc tests for self-monitoring health will lead to sizable demand in the market.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
The point-of-care testing (poct) market in europe is segmented as below:
By Type
- OTC testing
- Prescription-based testing
By Application
- Blood glucose testing
- Infectious diseases testing
- Cardiac markers testing
- Pregnancy and fertility testing
- Others
By Platform
- Lateral flow assays
- Immunoassays
- Molecular diagnostics
- Dipsticks
- Others
By Region
- Europe
The report covers the following areas:
- Point-of-care testing (poct) market in europe sizing
- Point-of-care testing (poct) market in europe forecast
- Point-of-care testing (poct) market in europe industry analysis
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Analysis
3 Market Landscape
4 Market Sizing
5 Historic Market Size
6 Qualitative Analysis
7 Five Forces Analysis
8 Market Segmentation by Type
9 Market Segmentation by Application
10 Market Segmentation by Platform
11 Customer Landscape
12 Geographic Landscape
13 Drivers, Challenges, and Opportunity
14 Competitive Landscape
15 Competitive Analysis
16 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global point-of-care testing (poct) market in europe: A. Menarini Industrie Farma, Abbott Laboratories, ACON Laboratories Inc., Becton Dickinson and Co., BioMerieux SA, Chembio Diagnostics Inc., Danaher Corp., LifeScan IP Holdings LLC, Nova Biomedical Corp., OraSure Technologies Inc., PHC Holdings Corp., Siemens Healthineers AG, Sinocare Inc., Sysmex Corp., Thermo Fisher Scientific Inc., Trinity Biotech Plc.Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is adoption of ai and data analytics in poct."
According to the report, one of the major drivers for this market is the shift toward rapid diagnostics over traditional labs.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- A. Menarini Industrie Farma
- Abbott Laboratories
- ACON Laboratories Inc.
- Becton Dickinson and Co.
- BioMerieux SA
- Chembio Diagnostics Inc.
- Danaher Corp.
- LifeScan IP Holdings LLC
- Nova Biomedical Corp.
- OraSure Technologies Inc.
- PHC Holdings Corp.
- Siemens Healthineers AG
- Sinocare Inc.
- Sysmex Corp.
- Thermo Fisher Scientific Inc.
- Trinity Biotech PLC
